GenapSys Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Out of Business

  • Employees
  • 83

Employees

  • Latest Deal Type
  • Bankr. Admin/​Reorg

GenapSys General Information

Description

Developer of a genomic sequencing ecosystem designed to empower both academic and clinical research applications. The company's technology leverages a proprietary electrical microfluidic sequencing chip with a scalable number of detectors and helps for applications ranging from targeted sequencing of specific amplicons to genome-scale sequencing data collection, enabling researchers or clinicians to deliver cost-effective and precise genetic testing and research.

Contact Information

Website
www.genapsys.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 200 Cardinal Way
  • 3rd Floor
  • Redwood City, CA 94063
  • United States
+1 (650)
Primary Industry
Application Specific Semiconductors
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Digital Health, HealthTech, Life Sciences
Corporate Office
  • 200 Cardinal Way
  • 3rd Floor
  • Redwood City, CA 94063
  • United States
+1 (650)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GenapSys Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Bankruptcy: Admin/Reorg 14-Jul-2022 Completed Bankruptcy: Admin/Reorg
10. Later Stage VC (Series D) 27-May-2021 Completed Generating Revenue
9. Debt - PPP 10-Apr-2020 Completed Generating Revenue
8. Debt - General 06-Feb-2020 Completed Generating Revenue
7. Later Stage VC (Series C) 20-Nov-2019 Completed Generating Revenue
6. Later Stage VC (Series C) 02-Jan-2018 Completed Generating Revenue
5. Grant 01-Jan-2015 Completed Generating Revenue
4. Early Stage VC (Series B) 21-Nov-2013 Completed Generating Revenue
3. Early Stage VC (Series A) 21-Mar-2013 $8.49M $8.49M Completed Generating Revenue
2. Grant 01-Sep-2012 $4M Completed Generating Revenue
To view GenapSys’s complete valuation and funding history, request access »

GenapSys Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series D
Series C
Series B 6,127,325 $0.001000 $5.95 $5.95 1x $5.95 10.92%
Series A 8,493,002 $0.001000 $1 $1 1x $1 15.13%
To view GenapSys’s complete cap table history, request access »

GenapSys Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a genomic sequencing ecosystem designed to empower both academic and clinical research applications. The co
Application Specific Semiconductors
Redwood City, CA
83 As of 2022

Oxford, United Kingdom
 

Cambridge, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

GenapSys Competitors (7)

One of GenapSys’s 7 competitors is Oxford Nanopore Technologies, a Formerly VC-backed company based in Oxford, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Oxford Nanopore Technologies Formerly VC-backed Oxford, United Kingdom
GnuBIO Formerly VC-backed Cambridge, MA
Illumina Formerly VC-backed San Diego, CA
Pacific BioSciences of California Formerly VC-backed Menlo Park, CA
Guardant Health Formerly VC-backed Palo Alto, CA
You’re viewing 5 of 7 competitors. Get the full list »

GenapSys Patents

  • 51

    Total Documents Applications and Grants

  • Total Patents Families

  • 22

    Granted

  • Pending

  • Expiring in next 12 mo

GenapSys Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2021168097-A1 Methods and systems for nucleic acid processing Inactive 19-Feb-2020
WO-2021163621-A2 Methods and systems for nucleic acid amplification and sequencing Inactive 14-Feb-2020
WO-2021163621-A3 Methods and systems for nucleic acid amplification and sequencing Inactive 14-Feb-2020
JP-2023040054-A Systems and methods for nucleic acid sequencing Inactive 21-Sep-2017
WO-2019060628-A1 Systems and methods for nucleic acid sequencing Inactive 21-Sep-2017 C12Q1/6869
To view GenapSys’s complete patent history, request access »

GenapSys Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

GenapSys FAQs

  • When was GenapSys founded?

    GenapSys was founded in 2010.

  • Where is GenapSys headquartered?

    GenapSys is headquartered in Redwood City, CA.

  • What is the size of GenapSys?

    GenapSys has 83 total employees.

  • What industry is GenapSys in?

    GenapSys’s primary industry is Application Specific Semiconductors.

  • Is GenapSys a private or public company?

    GenapSys is a Private company.

  • What is GenapSys’s current revenue?

    The current revenue for GenapSys is .

  • How much funding has GenapSys raised over time?

    GenapSys has raised $313M.

  • Who are GenapSys’s competitors?

    Oxford Nanopore Technologies, GnuBIO, Illumina, Pacific BioSciences of California, and Guardant Health are some of the 7 competitors of GenapSys.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process